Celemics

Celemics

Celemics is a personalized medicine company based in Seoul, Korea.

All edits

Edits on 11 April, 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 11 April, 2019 7:39 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 19 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 March, 2019 10:45 pm
Edits made to:
Article (+3/-3 characters)

Article

Targeted Sequencing involves isolating genomic regions of interest from the whole genome and utilizes synthetic strands of DNA or RNARNA called probes, which assist in detecting the presence of a gene in a long DNA sequence. In order to address uniformity and coverage limitations associated with Targeted Sequencing, Celemics has developed and introduced a technology which incorporates rebalancing of probes following a pre-production pilot test.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 March, 2019 10:41 pm
Edits made to:
Article (+5/-5 characters)

Article

Celemics Inc., a privately held company based in SeoulSeoul, South Korea, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. In addition to test kit manufacturing, Celemics also provides a full spectrum of Next Generation Sequencing and Bioinformatics services to university researchers, hospitals, care providers, and pharmaceutical organizations.

Edits on 19 March, 2019
Golden AI
Golden AI edited on 19 March, 2019 3:14 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 13 March, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 13 March, 2019 8:22 pm
Edits made to:
Article (+11/-11 characters)

Article

Celemics Inc., a privately held company based in Seoul, South KoreaSouth Korea, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. In addition to test kit manufacturing, Celemics also provides a full spectrum of Next Generation Sequencing and Bioinformatics services to university researchers, hospitals, care providers, and pharmaceutical organizations.

Edits on 11 March, 2019
Rebecca Hammond
Rebecca Hammond approved a suggestion from Golden's AI on 11 March, 2019 9:23 am
Edits made to:
Article (+4/-4 characters)

Article

Celemics manufactures the Next Generation Sequencing test kit in AsiaAsia and Europe. Next Generation Sequencing, or NGS, facilitates both hereditary and somatic genetic testing.

Edits on 8 March, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 8 March, 2019 10:48 am
Edits made to:
Article (+6/-6 characters)

Article

Celemics manufactures the Next Generation Sequencing test kit in Asia and EuropeEurope. Next Generation Sequencing, or NGS, facilitates both hereditary and somatic genetic testing.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 8 March, 2019 12:56 am
Edits made to:
Article (+14/-14 characters)

Article

Celemics Inc., a privately held company based in Seoul, South Korea, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. In addition to test kit manufacturing, Celemics also provides a full spectrum of Next Generation Sequencing and BioinformaticsBioinformatics services to university researchers, hospitals, care providers, and pharmaceutical organizations.

Edits on 5 March, 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 5 March, 2019 2:48 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 4 October, 2018
Carla Faraguna
Carla Faraguna edited on 4 October, 2018 9:39 pm
Edits made to:
Infobox (+1 properties)
Description (+56/-1 characters)
Article (+1126 characters)
Categories (+1 topics)
Topic thumbnail

Celemics

A personalized medicine company based in Seoul, Korea.

Article

Celemics Inc., a privately held company based in Seoul, South Korea, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. In addition to test kit manufacturing, Celemics also provides a full spectrum of Next Generation Sequencing and Bioinformatics services to university researchers, hospitals, care providers, and pharmaceutical organizations.

In October 2015 Celemics announced its expansion into the North American market with the establishment of Celemics America, Inc.

Celemics manufactures the Next Generation Sequencing test kit in Asia and Europe. Next Generation Sequencing, or NGS, facilitates both hereditary and somatic genetic testing.

...

Targeted Sequencing involves isolating genomic regions of interest from the whole genome and utilizes synthetic strands of DNA or RNA called probes, which assist in detecting the presence of a gene in a long DNA sequence. In order to address uniformity and coverage limitations associated with Targeted Sequencing, Celemics has developed and introduced a technology which incorporates rebalancing of probes following a pre-production pilot test.

Infobox

Categories

Edits on 2 October, 2018
Jude Gomila
Jude Gomila edited on 2 October, 2018 2:42 am
Edits made to:
Description (+1 characters)

Celemics

Jude Gomila"Initial topic creation"
Jude Gomila created this topic on 2 October, 2018 2:42 am
Edits made to:
Topic thumbnail

 Celemics

A personalized medicine company based in Seoul, Korea.

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.